Nxstage Medical, Inc. (NXTM) Tops Q2 EPS by 1c; Guides Q3 EPS, Revs
Tweet
Share
E-mailGet Alerts NXTM Hot Sheet
Price: $30.00 --0%
Financial Fact:
Provision for income taxes: 324K
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Provision for income taxes: 324K
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Nxstage Medical, Inc. (NASDAQ: NXTM) reported Q2 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $65.5 million versus the consensus estimate of $64.66 million.
Nxstage Medical, Inc. sees Q3 2013 EPS of ($0.07)-($0.06), versus the consensus of ($0.06). Nxstage Medical, Inc. sees Q3 2013 revenue of $66.5-68.0 million, versus the consensus of $67.6 million.
For earnings history and earnings-related data on Nxstage Medical, Inc. (NXTM) click here.
Nxstage Medical, Inc. sees Q3 2013 EPS of ($0.07)-($0.06), versus the consensus of ($0.06). Nxstage Medical, Inc. sees Q3 2013 revenue of $66.5-68.0 million, versus the consensus of $67.6 million.
For earnings history and earnings-related data on Nxstage Medical, Inc. (NXTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Cuprina to buy seven-clinic Singapore healthcare group for S$4M
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
